folate receptor beta immunotoxins (Innovatis)

N/A

Report date: 2025/06/11 20:01:15

Base Information

Drug Namefolate receptor beta immunotoxins (Innovatis)

Drug Alias NameINNOVA-101IP-1001E

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody fragmentBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody conjugate > Monoclonal antibody conjugateBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody conjugate

Mechanisms of ActionFolate receptor beta modulators

TargetsFolate receptor beta

Therapy Area/IndicationsInflammationNeoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryJapan

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesInnovatis Pharma Corp

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesInnovatis Pharma Corp

Active IndicationsN/A

Inactive IndicationsInflammationNeoplasms

Other Information

ATC CodeN/A